Asian Surveying & Mapping
Breaking News
Australian Space Agency funds development of aerospace-grade GNSS receiver
The Australian Space Agency has funded the development of...
Continuity risks for Australian EO data access
A new report details the widespread use of Earth...
China launches new remote sensing satellite
JIUQUAN, April 15 (Xinhua) -- China on Monday launched...
7.4-Magnitude Earthquake Strikes Taiwan
A major, 7.4-magnitude earthquake struck the eastern coast of...
Tata Deploys Its Geospatial Satellite In Space on Space X’s Falcon 9 Rocket
THIRUVANANTHAPURAM: Tata Company launched India's first private commercial satellite...
Taiwan’s Formosat-8 Satellite Set for Launch by 2025
The Taiwan Space Agency has announced progress on the...
Iranian Scientists to Build Satellite Constellation for 2 Simultaneous Missions
The scientists at the knowledge-based company had previously succeeded...
China provides geospatial intel and other military support to Russia, US says
The US has warned its European allies that China...
Japanese lunar lander company ispace raises $53.5 million in stock sale
WASHINGTON — Japanese lunar lander developer has raised $53.5...
Esri and Prince Sultan University Advance GIS Education Through Strategic Partnership
Memorandum of Understanding with Institution Enhances GIS Curriculum and...

June 29th, 2020
Topcon Announces the European Launch of MYAH

CAPELLE A/D IJSSEL, Netherlands – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched its new MYAH instrument to the European region. MYAH is a comprehensive management tool for eyecare professionals interested in building, managing and growing myopia and dry eye services within their practice or research institution.

The versatile, all-in-one MYAH provides all the critical tools needed to support myopia management while also offering an evolving platform to add or grow dry eye management. MYAH incorporates corneal topography including keratoconus screening and pupillometry, axial length measurements by optical low coherence interferometry, progression reports for analyzing treatment efficacy, and a comprehensive suite of dry eye assessment tools. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.

With the launch of MYAH, Topcon achieves a milestone in the battle against the global myopia epidemic. It is estimated that 50% of the world’s population, including European regions, may be myopic by 20501.

“MYAH is ideally suited to combat the growing crises of both myopia and dry eye disease. Its versatility and ease of use allows eyecare professionals to easily build a myopia service within their practice, educate patients on the implications of myopia and dry eye disease, manage their patients’ conditions, and grow their service offerings,” stated John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare.

For more information on MYAH, please visit www.topconmyah.com.

About Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and ground-breaking remote diagnostic technology.

A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

  1. Holden, BA, Fricke, TR, Wilson, DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036–42. Available from: doi: DOI: 10.1016/j.ophtha.2016.01.006